SpiroTact®

Rapid Syphilis Screening

Syphilis continues to be a growing global health issue, with over 7 million new cases annually (WHO) The syphilis diagnostics market is projected to exceed $3 billion by 2030, driven by rising infection rates. This increases the need for affordable, accessible diagnostics.
New Syphilis cases 0 Million per year
Pexels Tima Miroshnichenko 5452221

Syphilis remains a major global health challenge

Current diagnostic methods for the detection of Syphilis can be slow, complex, and expensive. Traditional serological testing often fails to differentiate between past and active infections, leading to misdiagnosis and delayed treatment, particularly in resource-limited settings.

Early detection and treatment is crucial to prevent complications, reduce transmission, and with regards to congenital Syphilis protect maternal and infant health.

Our Solution

2025 03 26 DetactDiagnostics CasperMaas CMA9053
SpiroTact®

Rapid, reliable Syphilis Detection

SpiroTact® is a rapid, user-friendly diagnostic test that directly detects active Treponema pallidum. Unlike, serological tests that could return positive results even in case of past infections, SpiroTact® is designed to detect active spirochete presence.

How SpiroTact® works

2025 03 26 DetactDiagnostics CasperMaas CMA9088
Collect

No Sample Prep

Directly transfer sample to the VIPER® assay tube containing the SpiroTact® assay
2025 03 26 DetactDiagnostics CasperMaas CMA9022
Read

Reader Agnostic

Place the VIPER® assay tube containing the sample, into the DeNIRO® mini Fluorometer (point-of-care) or plate reader (lab-based testing)
Roberto Sorin RS0 H PyByk Unsplash
Treat

Actionable Results

SpiroTact® provides actionable data within minutes enabling health care professionals to start immediate targeted treatment

Benefits to healthcare providers

Early Intervention

Enables prompt treatment to reduce transmission and complications

Fast Detection

Identifies Syphilis infections in minutes, not hours

Scalable & Affordable

Ideal for centralized clinics, but also for global health initiatives in resource poor environments

User friendly

Minimal training required for healthcare workers
SpiroTact Pilot Study

Pilot Study, East London, South Africa

In April 2024 Joost, Matt and Marleen from the Detact Team had the opportunity to travel to East London, South Africa, to visit the Foundation for Professional Development as part of development project on a syphilis diagnostic tool called SpiroTact®.

Our Point-of-Care NIR Fluorometer

Screenshot 2025 04 02 At 15.03.06

Breakthrough Technology – The VIPER® platform detects active infections with accuracy and speed

VIPER® Technology

Other VIPER® Applications

Chronic PJI
RenoTact®
Rapid Detection of PD Peritonitis
Allergies
SynoTact®
Rapid Detection of Periprosthetic Joint Infections
Peritonitis
MycoTact®
Rapid Detection of Tuberculosis Infection
Tuberculosis
EnzoTact®
Preventing Milk Spoilage with Rapid Protease Detection

SpiroTact® is currently for research use only and is not for use in diagnostic procedures; the performance characteristics of this product have yet to be established